What caused DNTH's EPS to drop in Q4 2023?

The specific cause of DNTH's EPS drop in Q4 2023 is not available. However, we can infer that it might be related to the significant decrease in total revenue for the same period. The revenue drop could be due to various factors such as market competition, pricing pressures, or operational inefficiencies. Without further information, it is challenging to pinpoint the exact reason. However, the company's leadership changes and insider transactions might provide some insights into the potential causes of the revenue decline. For instance, the departure of the Chief Medical Officer and the subsequent reduction in the stock price could indicate a lack of confidence in the company's future prospects. Similarly, the insider transactions, where insiders sold a significant amount of stock at a lower price, could suggest a lack of optimism about the company's short-term performance. Further analysis of the company's financial statements, market conditions, and business strategy would be necessary to fully understand the factors contributing to the EPS drop.